$200M at-the-market offering arrangement
Company: TeraWulf
The claim, verbatim
TeraWulf entered into a Sales Agreement with multiple agents dated April 26, 2022 (amended August 11, 2023 and May 23, 2024) to offer and sell up to $200,000,000 of common stock in at-the-market offerings
Source (primary)
TeraWulf 424B5 filed 2024-05-23 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “We have entered into a Sales Agreement with Cantor Fitzgerald & Co., ATB Capital Markets USA Inc., Compass Point Research & Trading, LLC, Northland Securities, Inc., Roth Capital Partners, LLC, Stifel Nicolaus Canada Inc., and Virtu Americas LLC (each, an "Agent" and, together, the "Agents"), dated April 26, 2022, as amended by Amendment No. 1, dated as of August 11, 2023 and Amendment No. 2, dated as of May 23, 2024 (together, the "Sales Agreement") relating to shares of our common stock, $0.001 par value per share ("Common Stock"), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, from time to time we may offer and sell shares of our Common Stock having an aggregate gross sales price of up to $200,000,000”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms TeraWulf 424B5 filed 2024-05-23
Quote: “We have entered into a Sales Agreement with Cantor Fitzgerald & Co., ATB Capital Markets USA Inc., Compass Point Research & Trading, LLC, Northland Securities, Inc., Roth Capital Partners, LLC, Stifel Nicolaus Canada Inc., and Virtu Americas LLC (each, an "Agent" and, together, the "Agents"), dated April 26, 2022, as amended by Amendment No. 1, dated as of August 11, 2023 and Amendment No. 2, dated as of May 23, 2024 (together, the "Sales Agreement") relating to shares of our common stock, $0.001 par value per share ("Common Stock"), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, from time to time we may offer and sell shares of our Common Stock having an aggregate gross sales price of up to $200,000,000”